This is not to say no one experiences symptoms on discontinuation of antidepressants, but trial data don’t show us this and they are the best method we have to find a causal association between antidepressants cessation and symptoms.

Why would researchers want to inflate the problem? It’s probably both ideological and financial www.wired.com/story/taperi...

Certainly from trials we see there is a unique profile of discontinuation symptoms, but the clinical impact is far less than some researchers would have you believe.

What about the lack of spell checker for comments? Shows me how much of my typing is just mashing the keyboard.

This target trial emulation study of >25k patients finds no difference in total cholesterol at one year, but lower BMI and BP. And no difference in psychiatric hospital admission rates journals.plos.org/plosmedicine...

Great work from @Alvin Richards-Belle et al.

High dose prescribing is more likely for: people with schizophrenia, minoritized ethic groups, younger people, men and people from more deprived areas

If bipolar then it’s quetiapine:

The patterns differ by diagnosis. If you have a schizophrenia, you are most likely to get olanzapine:

Hi there! Yes please